Shopping Cart
- Remove All
Your shopping cart is currently empty
Beta-Sheet Breaker Peptide iAβ5 Acetate
🥰Excellent
Catalog No. T21609L
Alias Beta-Sheet Breaker Peptide iAβ5 Acetate(182912-74-9 Free base)
Beta-Sheet Breaker Peptide iAβ5 Acetate (C33H43N5O8) inhibit amyloidogenesis in rat brain models.
Beta-Sheet Breaker Peptide iAβ5 Acetate
🥰Excellent
Purity: 99.68%
Catalog No. T21609LAlias Beta-Sheet Breaker Peptide iAβ5 Acetate(182912-74-9 Free base)
Beta-Sheet Breaker Peptide iAβ5 Acetate (C33H43N5O8) inhibit amyloidogenesis in rat brain models.
| Pack Size | Price | Availability | Quantity |
|---|---|---|---|
| 10 mg | $31 | In Stock | |
| 25 mg | $41 | In Stock | |
| 50 mg | $66 | In Stock | |
| 100 mg | $98 | In Stock | |
| 200 mg | $148 | In Stock | |
| 1 mL x 10 mM (in DMSO) | $34 | In Stock |
Add to Cart
Add to Quotation
Bulk & Custom
All TargetMol products are for research purposes only and cannot be used for human consumption. We do not provide products or services to individuals. Please comply with the intended use and do not use TargetMol products for any other purpose.
Questions
View MoreBatch Information
Select Batch
Purity:99.68%
Contact us for more batch information
Product Introduction
Bioactivity
Chemical Properties
| Description | Beta-Sheet Breaker Peptide iAβ5 Acetate (C33H43N5O8) inhibit amyloidogenesis in rat brain models. |
| In vivo | 5-residue peptide that inhibits amyloid beta-protein fibrillogenesis, disassembles preformed fibrils in vitro and prevents neuronal death induced by fibrils in cell culture. In addition, the beta-sheet breaker peptide significantly reduces amyloid beta-protein deposition in vivo and completely blocks the formation of amyloid fibrils in a rat brain model of amyloidosis. These findings may provide the basis for a new therapeutic approach to prevent amyloidosis in Alzheimer's disease. |
| Synonyms | Beta-Sheet Breaker Peptide iAβ5 Acetate(182912-74-9 Free base) |
| Molecular Weight | 697.78 |
| Formula | C35H47N5O10 |
| Smiles | O=C(O)C[C@@H](C(O)=O)NC([C@H](CC1=CC=CC=C1)NC([C@H](CC2=CC=CC=C2)NC([C@H]3N(C([C@H](CC(C)C)N)=O)CCC3)=O)=O)=O.CC(O)=O |
| Relative Density. | no data available |
| Color | White |
| Appearance | Solid |
| Sequence | H-Leu-Pro-Phe-Phe-Asp-OH |
| Sequence Short | LPFFD |
Storage & Solubility Information
| Storage | keep away from moisture | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | ||||||||||||||||||||||||||||||
| Solubility Information | DMSO: 60 mg/mL (85.99 mM), Sonication is recommended. | ||||||||||||||||||||||||||||||
Solution Preparation Table | |||||||||||||||||||||||||||||||
DMSO
| |||||||||||||||||||||||||||||||
Calculator
In Vivo Formulation Calculator (Clear solution)
Please enter your animal experiment information in the following box and click Calculate to obtain the mother liquor preparation method and in vivo formula preparation method:
For example, your dosage is 10 mg/kg Each animal weighs 20 g, and the dosage volume is 100 μL . A total of 10 animals were administered, and the formula you used is 5% 
DMSO+30% PEG300+5% Tween 80+60% Saline/PBS/ddH2O. So your working solution concentration is 2 mg/mL。Mother liquor preparation method: 2 mg of drug dissolved in 50 μL DMSO (mother liquor concentration of 40 mg/mL), if you need to configure a concentration that exceeds the solubility of the product, please contact us first.
(mother liquor concentration of 40 mg/mL), if you need to configure a concentration that exceeds the solubility of the product, please contact us first.Preparation method for in vivo formula: Take 50 μL DMSO main solution, add 300 μLPEG300 mix well and clarify, then add 50 more μL Tween 80, mix well and clarify, then add 600 more μLSaline/PBS/ddH2O mix well and clarify
main solution, add 300 μLPEG300 mix well and clarify, then add 50 more μL Tween 80, mix well and clarify, then add 600 more μLSaline/PBS/ddH2O mix well and clarifyFor Reference Only. Please develop an appropriate dissolution method based on your laboratory animals and route of administration.
Dose Conversion
You can also refer to dose conversion for different animals. More Dose Conversion
Sci Citations
Tech Support
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc
Keywords
Preview
Related Tags: buy Beta-Sheet Breaker Peptide iAβ5 Acetate | purchase Beta-Sheet Breaker Peptide iAβ5 Acetate | Beta-Sheet Breaker Peptide iAβ5 Acetate cost | order Beta-Sheet Breaker Peptide iAβ5 Acetate | Beta-Sheet Breaker Peptide iAβ5 Acetate chemical structure | Beta-Sheet Breaker Peptide iAβ5 Acetate in vivo | Beta-Sheet Breaker Peptide iAβ5 Acetate formula | Beta-Sheet Breaker Peptide iAβ5 Acetate molecular weight
- TOP
Feedback
Hello! How can I help you today? 
Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.